Comprehensive characterisation of the active ingredients of <i>Smilax glabra</i> Roxb based on chemical fingerprinting, metabolic fingerprinting and pharmacodynamic fingerprinting.

Front Pharmacol · 2025 · PMC12055767 · PMID 40337523

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < 0.01actually significant

There was a highly significant difference between the allopurinol group and the model group ( p < 0.01) and a significant difference between the medium-polar compound group and the model group ( p < 0.05), but no significant difference between the medium-polar compound group and the allopurinol group ( p > 0.05).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Comprehensive characterisation of the active ingredients of &lt;i&gt;Smilax glabra&lt;/i&gt; Roxb based on chemical fingerprinting, metabolic fingerprinting and pharmacodynamic fingerprinting.

The sentences

Comprehensive characterisation of the active ingredients of <i>Smilax glabra</i> Roxb based on chemical fingerprinting, metabolic fingerprinting and pharmacodynamic fingerprinting.